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Introduction

Results (cont.)

Materials and Methods (cont.)

•

• B-cells have been recognized as important
players in the immune system’s attack on
cancer.1
• However, their exact role in this process
and spatial relationship with malignant cells
(MCs) are not very clear, and these
concepts may be relevant to developing
new therapies.2

Between patients whose cancer had invaded
the pleural membrane and those whose had
not, there was a significant difference
between the number of B cells within 20 µm
of malignant cells (Figure 5).

Figure 1. Patient clinicopathological characteristics.

• Objectives: 1) To analyze B-cells’ density
within and their proximity to tumor in nonsmall cell lung cancer. 2) To correlate the
data to clinically relevant patient
information and other immune cell
populations.

• Intratumoral B-cell density was calculated and a B-cell-tumor 20
μm spatial proximity analysis was performed (Figure 3).

Materials and Methods

Figure 5. Patients whose cancer had invaded
the pleura displayed a significantly higher
number of B-cells within 20 µm of malignant
cells (p = 0.0162). PI = pleural invasion. NPI =
no pleural invasion.

• Twelve formalin-fixed paraffin-embedded
Stage I lung adenocarcinoma tissue
samples were obtained from the University
of Texas MD Anderson Cancer Center
archives (Figure 1).
• Each sample was probed with Syto13
(nucleus stain), for cytokeratin (tumor and
epithelium biomarker), for CD3 (T-cell
biomarker), and for CD20 (B-cell
biomarker) for morphology identification
(Figure 2). They were also probed with
nanoString panels for forty-nine immuneoncology proteins.
• The samples were processed by the
GeoMX digital spatial profiler (DSP), and
the images were exported to the image
analysis software HALO for analysis.

Conclusions
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Figure 3. Spatial proximity analysis using HALO. (A) First, the software uses a highplex
algorithm to perform cell segmentation and identifies the MCs, B-cells, and T-cells. (B) Then, it
identifies the specific B-cells and T-cells located within 20 μm of MCs and counts them.

Results
• There was a positive correlation between intratumoral B-cell
density and tumor size (r = 0.587, p = 0.045) (Figure 4a), and
within 20 µm of malignant cells, there was a positive correlation
between the number of B-cells and the overall cell densities of
tumoral macrophages and regulatory T-cells (Figure 4b).

• Our findings on the association
between high numbers of B-cells within
20 μm of malignant cells and high
densities of intratumoral macrophages
and regulatory T-cells suggests that the
presentation of tumor antigens is
promoted even when the overall
immune response is turned down.
• Future work may investigate whether
the same observations, including those
regarding pleural invasion and tumor
size, can be validated in a larger cohort
of samples.
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Figure 1. HALO displays the GeoMX DSP
immunofluorescent morphology biomarkers
simultaneously to reveal an intratumoral
lymphoid structure composed of B-cells
(yellow) and T-cells (red) in proximity to MCs
(green).

Figure 4a. Intratumoral B-cell Density was
positively correlated with tumor size (r =
0.587, p = 0.045).

Figure 4b. B-cell count within 20µm was
positively correlated with CD68+
macrophages (r = 0.5912, p = 0.0429),
CD68+/PD-L1- macrophages (r = 0.7609, p =
0.0041), and CD8-/FOXP3+/CD45ROregulatory T-cells (r = 0.6349, p = 0.0265)
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